August 7, 2013 — W. L. Gore & Associates announced a favorable ruling involving the Gore Helex Septal Occluder. The Hon. Judge Joan Ericksen of the U.S. District Court for the District of Minnesota ruled on July 23, 2013 in Gore’s favor that the Gore Helex Septal Occluder does not infringe the asserted claims of AGA Medical Corp.’s U.S. Patent 5,944,738 (‘738 patent) and granted Gore’s request for summary judgment of non-infringement.
In August 2010, Gore was sued for patent infringement by AGA, which became part of St. Jude Medical as of November 2010. AGA alleged that the Gore Helex Septal Occluder infringed some claims of AGA’s ‘738 patent, which covers certain transcatheter occlusion products for the treatment of heart defects. AGA sought damages against Gore and a permanent injunction prohibiting Gore from selling the Gore Helex Septal Occluder both in the United States and abroad.
AGA has the right to appeal this decision.
For more information: www.goremedical.com
June 20, 2024 
